Clinical trials
Trials in Namibia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 3 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 2 |
| University of Namibia | 2 |
| Prof Gerhard Walzl | 1 |
| Stanford University | 1 |
| Unity Health Toronto | 1 |
| University of KwaZulu | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria | 2 |
| Tuberculosis, Pulmonary | 2 |
| COVID-19 | 1 |
| Disease | 1 |
| HIV Seropositivity | 1 |
| Latent Tuberculosis | 1 |
| Tuberculosis | 1 |
| Tuberculosis, Multidrug-Resistant | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.